Non-neonatal tetanus is an acute,specific,toxic disease in patients over 28 days of age,characterized by continuous rigidity and paroxysmal spasms of the skeletal muscles throughout the body caused by the intrusion of Clostridium tetani through skin or mucosal membrane into the body and reproducing in anaerobic environments to produce exotoxins.The mortality rate of severe patients is close to 100％without medical intervention.Even with aggressive comprehensive treatment,the global mortality rate remains at 30％-50％,making it a potentially fatal disease.In order to standardize the diagnosis,treatment and prevention of non-neonatal tetanus,based on"Regulation for Diagnosis and Treatment of Non-neonatal Tetanus(2019 Edition)",experts have revised this regulation according to clinical practice and recent research progress in this field to guide medical institutions in the prevention and control of non-neonatal tetanus.This article interprets the key points and basis for updating the 2024 edition regulation to guide clinical implementation and application.
维普
万方数据